Current Liabilities
Current Debt
Bristol-Myers Squibb Current Debt increased by 2.1% to $2.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.1%, from $3.55B to $2.31B. Over 5 years (FY 2020 to FY 2025), Current Debt shows an upward trend with a 66.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase indicates higher near-term cash outflow requirements, potentially pressuring liquidity if cash flow is constrained.
Detailed definition
This represents the portion of long-term debt obligations that are scheduled to mature and require repayment within the...
Peer comparison
Peers typically manage this based on their debt maturity profile and access to credit markets.
Metric ID:
current_portion_long_term_debtHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $63M | $81M | $105M | $130M | $151M | $107M | $176M | $155M | $125M | $164M | $3.12B | $6.19B | $3.53B | $1.08B | $2.05B | $3.55B | $4.72B | $4.51B | $2.26B | $2.31B |
| QoQ Change | — | +28.6% | +29.6% | +23.8% | +16.2% | -29.1% | +64.5% | -11.9% | -19.4% | +31.2% | >999% | +98.5% | -43.0% | -69.5% | +89.8% | +73.7% | +32.7% | -4.4% | -49.9% | +2.1% |
| YoY Change | — | — | — | — | +139.7% | +32.1% | +67.6% | +19.2% | -17.2% | +53.3% | >999% | >999% | >999% | +557.3% | -34.4% | -42.6% | +33.5% | +318.3% | +10.5% | -35.1% |
Range$63M – $6.19B
CAGR+113.4%
Avg YoY Growth+587.0%
Median YoY Growth+43.4%
Current Debt at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's current debt?
- Bristol-Myers Squibb (BMY) reported current debt of $2.31B in Q1 2026.
- How has Bristol-Myers Squibb's current debt changed year-over-year?
- Bristol-Myers Squibb's current debt decreased by 35.1% year-over-year, from $3.55B to $2.31B.
- What is the long-term trend for Bristol-Myers Squibb's current debt?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's current debt has grown at a 66.6% compound annual growth rate (CAGR), from $176M to $2.26B.
- What does current debt mean?
- The amount of long-term debt that must be paid back within the next year.